bioMérieux Shares Dip 1.13% at Close Due to Technical Resistance
bioMérieux shares closed on Wednesday, January 7th at 113.50 euros, marking a decline of 1.13% from the previous day, facing technical resistance at 114.80 euro…
Follow today's market news in real time: CAC 40 prices, corporate announcements, financial releases and market information. This page automatically aggregates the latest briefs and press releases to give you the most up-to-date view of the moves driving the session.
bioMérieux shares closed on Wednesday, January 7th at 113.50 euros, marking a decline of 1.13% from the previous day, facing technical resistance at 114.80 euro…
Elis shares closed on Wednesday, January 7, 2026, at 24.98 euros, marking a 3.82% increase from the previous day. The European specialist in the rental and main…
Icade's stock closed Wednesday's session at 22.60 euros, up 5.12% from the previous day, surpassing key resistance levels and showing a positive technical stanc…
Société Générale ended the trading session on Wednesday, January 7, 2026, with a slight decrease of 1.06% at 69.12 euros, after reaching 69.86 euros the previou…
AXA's stock has shown resilience following a positive coverage resumption by Deutsche Bank, which set a buy recommendation with a price target of 45 euros, indi…
EssilorLuxottica's stock closed at 272.50 euros this Wednesday, January 7, marking a 1.7% decrease from the previous day's close of 277.20 euros, following a su…
Airbus shares closed up 2.08% at 213.75 euros this Wednesday, January 7, continuing its recent upward trend with a 7.44% increase over the week. The stock is no…
L'Oréal's stock closed at 356 euros this Wednesday, January 7, marking a decline of 3.44% from the previous day's 368.70 euros. The stock traded 0.07% of its ca…
Saint-Gobain's stock closed on Wednesday, January 7, 2026, at 84.08 euros, marking a 0.94% increase from the previous day. This follows two consecutive sessions…
DISCLAIMER: This information is not contractual in nature and carries no guarantee of accuracy. It should not be considered investment advice. Ideal-investisseur.fr cannot be held liable for any damages or losses arising from the use of this information.
